Advanced Search
NIAID
>
Labs & Scientific Resources
>
Resources for Researchers
>
DMID Resources for Researchers
>
In Vitro Antiviral Screening Program
In Vitro Antiviral Screening Program
Eligibility Criteria
Assurances to Users
Application Process
Approval Process
User Requirements
Services for Researchers
In Vitro Antiviral Screening Program
Prioritization and Approval Process
Materials for testing are selected and prioritized by relevant program officers from the Division of Microbiology and Infectious Diseases (DMID). Submitted compounds will be evaluated based on criteria such as structural novelty and drug-like characteristics as well as the rationale for submission, program priorities, and budgeted capacities in the antiviral screens requested. Final decisions are communicated to the submitter by the NIAID Project Officer.
Contact Info
Christopher Tseng
DMID Program Officer
E-mail:
ctseng@niaid.nih.gov
Web Site Tools
E-mail this page
Print this page
Bookmark & share
Contact Info
Christopher Tseng
DMID Program Officer
E-mail:
ctseng@niaid.nih.gov
Last Updated July 2, 2008
Home
|
Help
|
Site Index
|
Accessibility
|
Privacy Policy
|
Disclaimer
|
Links & Policies
|
FOIA
|
Contact Us